Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
9,614,000
-
Total 13F shares
-
24,890,216
-
Share change
-
+175,745
-
Total reported value
-
$233,607,844
-
Put/Call ratio
-
172%
-
Price per share
-
$9.38
-
Number of holders
-
91
-
Value change
-
+$136,252
-
Number of buys
-
46
-
Number of sells
-
37
Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q3 2021
As of 30 Sep 2021,
Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,890,216 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, FRANKLIN RESOURCES INC, BlackRock Inc., RTW INVESTMENTS, LP, Logos Global Management LP, VANGUARD GROUP INC, VR Adviser, LLC, PATHSTONE FAMILY OFFICE, LLC, CITADEL ADVISORS LLC, and WASATCH ADVISORS INC.
This page lists
91
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.